Chiba-ken, Japan

Akio Matsunaga


Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Mobara, JP (1998)
  • Chiba-ken, JP (1998)

Company Filing History:


Years Active: 1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akio Matsunaga: Innovator in Anticancer and Antiviral Agents

Introduction

Akio Matsunaga is a prominent inventor based in Chiba-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as anticancer, antiviral, and antimicrobial agents. With a total of 3 patents to his name, Matsunaga's work is recognized for its potential impact on medical treatments.

Latest Patents

Matsunaga's latest patents include innovative compounds such as benzimidazole derivatives and phenylbenzimidazole derivatives. These compounds are described as active ingredients that act on DNA, showcasing their potential as effective agents in combating various diseases. The formulations presented in his patents highlight the importance of his research in the pharmaceutical industry.

Career Highlights

Throughout his career, Akio Matsunaga has been associated with Mitsui Chemicals, Inc., where he has contributed to groundbreaking research and development. His work has not only advanced the understanding of pharmaceutical compounds but has also paved the way for new treatment options in the medical field.

Collaborations

Matsunaga has collaborated with notable colleagues such as Hiroshi Kohno and Hajime Edatsugi. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Akio Matsunaga's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…